VirusDisease最新文献

筛选
英文 中文
Genotype-specific codon usage patterns differentiate swine-associated hepatitis E virus A3 and A4: Insights into evolutionary constraints. 基因型特异性密码子使用模式区分猪相关戊型肝炎病毒A3和A4:对进化约束的见解
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-08-29 DOI: 10.1007/s13337-026-00986-6
Roopa Mahadevaswamy, Vijay Muruganantham, Sharanagouda Patil, Shijili Mambully, Varsha Ramesh, Kuralayanapalya Puttahonnappa Suresh, Jagadish Hiremath, Shivasharanappa Nayakvadi
{"title":"Genotype-specific codon usage patterns differentiate swine-associated hepatitis E virus A3 and A4: Insights into evolutionary constraints.","authors":"Roopa Mahadevaswamy, Vijay Muruganantham, Sharanagouda Patil, Shijili Mambully, Varsha Ramesh, Kuralayanapalya Puttahonnappa Suresh, Jagadish Hiremath, Shivasharanappa Nayakvadi","doi":"10.1007/s13337-026-00986-6","DOIUrl":"10.1007/s13337-026-00986-6","url":null,"abstract":"<p><p>Hepatitis E virus (HEV) genotypes A3 and A4 are predominantly associated with swine and have been reported in zoonotic infections. Differences in codon usage between these genotypes within a common swine reservoir remain poorly characterized. This study analyzed 114 complete coding sequences of swine-associated HEV-A3 (<i>n</i> = 62) and HEV-A4 (<i>n</i> = 52). Nucleotide composition, relative synonymous codon usage (RSCU), effective number of codons (ENC), neutrality, parity rule 2 (PR2), dinucleotide abundance, codon adaptation index (CAI), principal component analysis (PCA), PERMANOVA, and site-specific selection analyses were performed for the complete coding region and separately for ORF1, ORF2, and ORF3. Both genotypes were GC-rich, with GC3 values of 57.66% in HEV-A3 and 59.89% in HEV-A4, while ORF3 showed higher GC3 than ORF1 and ORF2. RSCU analysis identified shared and genotype-specific synonymous codon preferences. Mean ENC values indicated moderate codon usage bias, with slightly lower values in HEV-A4 at the complete coding-region level. Neutrality and PR2 analyses indicated weak relationships and nucleotide asymmetry at synonymous third codon positions, respectively. CpG showed relative depletion in both genotypes. CAI differed between HEV-A3 and HEV-A4 at the complete coding-region level, and ORF-level analysis showed significant differences in ORF1 and ORF3 but not ORF2. Selection analyses indicated predominant purifying selection with localized pervasive and episodic diversifying signals that varied among ORFs. PCA and PERMANOVA supported significant differences in codon usage composition between HEV-A3 and HEV-A4 (R² = 0.24, <i>p</i> = 0.001). Overall, codon usage variation was genotype-specific and ORF-dependent, consistent with contributions from nucleotide composition, host-associated codon compatibility, and heterogeneous evolutionary constraints.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13337-026-00986-6.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"396-403"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India. 印度中部SARS-CoV-2重组基因组变体XBB.1.16的分离及基因组特征分析
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-07-22 DOI: 10.1007/s13337-026-00974-w
Rohit Menon, Sushil Kumar Sharma, Anshuman Behera, Ambuj Shrivastava, Shashi Sharma, Jyoti S Kumar, Paban Kumar Dash, Manmohan Parida
{"title":"Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India.","authors":"Rohit Menon, Sushil Kumar Sharma, Anshuman Behera, Ambuj Shrivastava, Shashi Sharma, Jyoti S Kumar, Paban Kumar Dash, Manmohan Parida","doi":"10.1007/s13337-026-00974-w","DOIUrl":"10.1007/s13337-026-00974-w","url":null,"abstract":"<p><p>Despite the World Health Organization's declaration in May 2023 of the end of the Public Health Emergency of International Concern (PHEIC), COVID-19 continues to circulate globally. As such, the continued transmission across the different parts of the globe resulted in the emergence of variants which could pose a constant challenge to public health. The isolation of circulating virus variants during these times is essential to assess the impact of the strains and establish effective counter-measures if necessary. This study focuses on the isolation and characterization of the SARS-CoV-2 recombinant Omicron variant XBB.1.16 from a clinical sample in Central India, collected during an early 2023 surge. Using a throat swab, confirmation of the variant by qRT-PCR and distinctive Cytopathic Effects (CPE) were observed on the Vero E6 cell line. The isolation by passages of the virus was found to be successful through positive qRT-PCR and next-generation sequencing (NGS). The isolate was found to be XBB.1.16, Clade GRA, a Variant of Interest (VOI) after sequencing. Detailed analysis of the spike gene indicated 53 mutations leading to 45 amino acid substitutions compared to the original Wuhan strain.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13337-026-00974-w.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"296-303"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary association between infectious bronchitis virus viral load and the tracheal microbiome of broiler chickens. 肉鸡传染性支气管炎病毒载量与气管微生物群的初步关系。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-08-21 DOI: 10.1007/s13337-026-00980-y
Mohammad Bani-Amer, Seif Hundam, Mustafa Ababneh, Mohammad Borhan Al-Zghoul, Daoud Alghizzawi, Ibrahim Abualghusein, Ala A Al-Ghawanmeh
{"title":"Preliminary association between infectious bronchitis virus viral load and the tracheal microbiome of broiler chickens.","authors":"Mohammad Bani-Amer, Seif Hundam, Mustafa Ababneh, Mohammad Borhan Al-Zghoul, Daoud Alghizzawi, Ibrahim Abualghusein, Ala A Al-Ghawanmeh","doi":"10.1007/s13337-026-00980-y","DOIUrl":"10.1007/s13337-026-00980-y","url":null,"abstract":"<p><p>Infectious bronchitis virus (IBV) is a major respiratory pathogen in poultry, yet its impact on the tracheal microbiota under field conditions remains insufficiently understood. This study investigated the effects of IBV infection intensity on tracheal microbial diversity and composition in broiler chickens using 16 S rRNA gene sequencing. A total of 200 tracheal samples were collected from commercial farms and screened using RT-qPCR. Samples were stratified into high, low, and negative viral load groups based on cycle threshold (Ct) values, and a representative subset was selected for microbiome analysis. Alpha diversity analysis revealed a significant reduction in microbial richness (Observed species and Chao1 indices; q < 0.05) in the low-viral-load group compared with controls, while Shannon diversity remained unchanged, suggesting a selective loss of rare taxa. In contrast, no significant changes in alpha diversity were observed in the high viral load group. Beta-diversity analysis based on Bray-Curtis dissimilarity (PERMANOVA) revealed significant differences in microbial community composition among different viral load groups. Taxonomic analysis showed stability at the phylum level, with more pronounced shifts at the genus level. These findings indicate that IBV infection induces selective and load-dependent alterations in the tracheal microbiota. Notably, treating infection as a binary variable may obscure ecologically meaningful and biologically relevant microbial shifts. This preliminary field study provides evidence that IBV viral load is associated with differences in the respiratory microbiome of broiler chickens under field conditions.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"372-381"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the role of non-structural proteins in the life cycle of chikungunya virus. 揭示非结构蛋白在基孔肯雅病毒生命周期中的作用。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-07-28 DOI: 10.1007/s13337-026-00973-x
Komal Chhikara, Dipesh Kumar Verma, Poonam Kanta, Kapil Goyal, Arnab Ghosh, Mini P Singh
{"title":"Unraveling the role of non-structural proteins in the life cycle of chikungunya virus.","authors":"Komal Chhikara, Dipesh Kumar Verma, Poonam Kanta, Kapil Goyal, Arnab Ghosh, Mini P Singh","doi":"10.1007/s13337-026-00973-x","DOIUrl":"10.1007/s13337-026-00973-x","url":null,"abstract":"<p><p>Chikungunya is a re-emerging neglected tropical disease that has recently become aglobal health concern due to its increasing burden and substantial geographicalexpansions. It is caused by the Chikungunya virus (CHIKV, an alphavirus), whichbelongs to the family Togaviridae and is transmitted by the Aedes mosquito. TheChikungunya infection is usually self-limiting during the acute phase, but incapacitatingarthralgia is the major cause of morbidity. At present, no specific antiviral is availablefor treatment, and current guidelines generally aim to reduce symptoms rather thantarget the virus directly. Recently, two vaccine approved for high-risk population andtravelers; however, these vaccines are not incorporated into routine immunizationprogrammes. There is an urgent need to develop a direct acting antiviral againstCHIKV. With respect to CHIKV, many proteins (structural or non-structural) can bepotential targets against which compounds can be developed or identified and hence,considering the pivotal role of non-structural proteins in viral replication, interaction withhost cells, and virus propagation. Therefore, non-structural proteins are potentialtargets for antiviral intervention. The present review aims to unravel the structure andfunctions roles of Chikungunya non-structural proteins to understand domain-specificpathogenesis and disease progression.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"231-252"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Virology Meets the Viruses of the Changing World: Where Ecology, Evolution, One Health, Artificial Intelligence, and Innovation Unite to Decode Viruses. 全球病毒学与不断变化的世界的病毒相遇:生态,进化,同一健康,人工智能和创新联合起来解码病毒。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-10-10 DOI: 10.1007/s13337-026-00989-3
Shailendra K Saxena
{"title":"Global Virology Meets the Viruses of the Changing World: Where Ecology, Evolution, One Health, Artificial Intelligence, and Innovation Unite to Decode Viruses.","authors":"Shailendra K Saxena","doi":"10.1007/s13337-026-00989-3","DOIUrl":"https://doi.org/10.1007/s13337-026-00989-3","url":null,"abstract":"<p><p>This article highlights the current issue of <i>VirusDisease</i> in the fast-changing scenario of modern virology and introduces the VIROCON 2026, the flagship national conference of the Indian Virological Society, which will be held in Thiruvananthapuram, Kerala, on 11-13 November 2026 with the theme <i>\"Viruses in the ChangingWorld: Ecology</i>, <i>Evolution and Future Preparedness.\"</i> The current issue covers the wide range of contemporary virological research, including molecular and structural virology, emerging and re-emerging viruses, diagnostics, computational methods, epidemiology, co-infections, and viral evolution. VIROCON 2026 builds on this interdisciplinary perspective with eight thematic tracks that combine One Health, AI, metagenomics, ecology, climate change, therapeutics, vaccines, and preparedness. The issue and conference highlight the need for collaboration, innovation, and globally connected virology to prepare for and address future viral threats.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"225-230"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An updated review of monkeypox virus infection's global prevalence and health risks with supporting treatment and diagnosis. 猴痘病毒感染全球流行和健康风险的最新综述,并提供支持性治疗和诊断。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-08-31 DOI: 10.1007/s13337-026-00981-x
Krishna Kumar Bharti, Sunit Kumar Gupta, Bhaskarjyoti Saha, Uttam Prasad Panigrahy
{"title":"An updated review of monkeypox virus infection's global prevalence and health risks with supporting treatment and diagnosis.","authors":"Krishna Kumar Bharti, Sunit Kumar Gupta, Bhaskarjyoti Saha, Uttam Prasad Panigrahy","doi":"10.1007/s13337-026-00981-x","DOIUrl":"10.1007/s13337-026-00981-x","url":null,"abstract":"<p><p>Monkeypox disease develops from the monkeypox virus, which contains double-stranded DNA and belongs to the orthopoxvirus genus found under the family Poxviridae, subfamily Chordopoxvirinae. The WHO director declared the multiregional monkeypox outbreak an international public health emergency. This review aims to summarise the pathogenesis, virology, epidemiology, clinical features, diagnostics, the available therapeutic and prophylactic measures, as well as future perspectives, research gaps, and global preparedness for monkeypox. Monkeypox virus has an architectural resemblance to the variola virus but has its own genetic and pathogenic characteristics. Monkeypox virus has evolved globally to spread from specific African regions to cause human-to-human transmission in other worldwide territories. Standard clinical signs, including fever and headache pain along with muscle pain, swollen lymph nodes, and rashes in specific body regions, manifest as the first step of diagnosis. Traditional polymerase chain reaction together with real-time polymerase chain reaction (RT-PCR) stands as the main diagnostic tool that healthcare providers use with imaging studies for complication assessment. Some antiviral drugs, including tecovirimat, cidofovir, and brincidofovir, are FDA-approved for the treatment of smallpox and are used for mpox under the Expanded Access Investigational New Drug (EA-IND) protocol or other authorised investigational/off-label settings for eligible patients. JYNNEOS (IMVANEX) is approved by the FDA and EMA for the prevention of both smallpox and mpox, whereas ACAM2000 is approved for smallpox and may be used for mpox in specific off-label or public health settings. The primary preventive strategy involves community-oriented preventive initiatives for infectious diseases, including future studies regarding gaps in vaccinations, the dynamics of transmission, and enhancing the preparedness of global health systems. The comprehensive review reveals Mpox disease history and current knowledge through a systematic evaluation of disease source, virology, disease transmission and clinical presentation, detection, management and prevention approaches and future plans to stop this infection.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"253-270"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the quantiplus rabies virus detection kit for diagnosis of rabies in humans and animals. 定量+狂犬病毒检测试剂盒用于人、动物狂犬病诊断的评价。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-08-20 DOI: 10.1007/s13337-026-00979-5
Shubhangi Chandel, Lonika Lodha, Preeti Soundarya Bhalke, Arpita Maladakar, Sathya Priya Manuel, Manoor Ananda Ashwini, Shrikrishna Isloor, Reeta S Mani
{"title":"Evaluation of the quantiplus rabies virus detection kit for diagnosis of rabies in humans and animals.","authors":"Shubhangi Chandel, Lonika Lodha, Preeti Soundarya Bhalke, Arpita Maladakar, Sathya Priya Manuel, Manoor Ananda Ashwini, Shrikrishna Isloor, Reeta S Mani","doi":"10.1007/s13337-026-00979-5","DOIUrl":"10.1007/s13337-026-00979-5","url":null,"abstract":"<p><p>Rabies, a fatal zoonotic encephalitis, causes approximately 60,000 deaths annually worldwide. The current gold standard for laboratory confirmation is the direct fluorescent antibody test (DFAT) on postmortem brain samples. To overcome the limitations of DFAT, real-time PCR for rabies viral RNA detection has emerged as a reliable alternative for both antemortem and postmortem samples. This study evaluates the diagnostic performance of the Quantiplus Rabies Virus Detection Kit, a commercially available real-time PCR kit for detecting rabies RNA. The study included 24 postmortem human brain samples, 14 antemortem human samples (cerebrospinal fluid, saliva, and nuchal skin), and 44 postmortem animal brain samples. DFAT and Quantiplus assays were performed on brain samples, while Real-time TaqMan RT-PCR and Quantiplus assays were used on antemortem human samples. Using DFAT as the reference standard, the Quantiplus assay demonstrated 100% sensitivity and specificity for human and animal brain samples. It showed agreement with the in-house RT-PCR for antemortem human samples (Cohen's Kappa 1). Notwithstanding the relatively small sample size in this study, the Quantiplus assay is a reliable alternative to in-house RT-PCR for rabies diagnosis, enhancing surveillance and control efforts toward eliminating dog-mediated rabies deaths by 2030.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"391-395"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis and prediction of anti-Chandipura virus molecules as drug and vaccine candidates. 抗钱迪普拉病毒分子作为候选药物和疫苗的分析和预测。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-08-25 DOI: 10.1007/s13337-026-00983-9
Abid Qureshi, Ehtishamul Haq
{"title":"Analysis and prediction of anti-Chandipura virus molecules as drug and vaccine candidates.","authors":"Abid Qureshi, Ehtishamul Haq","doi":"10.1007/s13337-026-00983-9","DOIUrl":"10.1007/s13337-026-00983-9","url":null,"abstract":"<p><p>Chandipura virus (CHPV) belongs to the Rhabdoviridae family and has emerged as a significant cause of acute encephalitis outbreaks in India, particularly affecting children. It is mostly transmitted during monsoons in rural areas through sandflies and mosquitoes. Its genome encodes 5 proteins: Nucleoprotein (N), Phosphoprotein (P), Matrix (M), Glycoprotein (G), and Large polymerase (L). These virus factors can serve as key targets for both drug discovery and vaccine development. Antiviral therapeutics for this pathogen are in demand but currently lacking. In this resource, predicted drug candidates have been identified through molecular docking and virtual screening approaches. In addition, top B and T cell epitopes (MHC I and II) having suitable antigenic potential, hydrophilicity, accessibility and binding affinity were identified through immunoinformatics approaches. These findings have broad applications in both drug discovery and immunoinformatics-based multi-epitope vaccine design. The resource is accessible via https://bio-ai.in/biovir/ and http://biovir.scienceontheweb.net/.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"350-356"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-based virtual screening and molecular dynamics reveal saquinavir as a potential inhibitor of the Bhanja virus nucleoprotein. 基于结构的虚拟筛选和分子动力学显示沙奎那韦是一种潜在的巴尼亚病毒核蛋白抑制剂。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-07-07 DOI: 10.1007/s13337-026-00972-y
Md Aquib Khan, Sarfraz Anwar, Ankur Singh, Shivani Tyagi, Sintu Kumar Samanta, Pramod Katara
{"title":"Structure-based virtual screening and molecular dynamics reveal saquinavir as a potential inhibitor of the Bhanja virus nucleoprotein.","authors":"Md Aquib Khan, Sarfraz Anwar, Ankur Singh, Shivani Tyagi, Sintu Kumar Samanta, Pramod Katara","doi":"10.1007/s13337-026-00972-y","DOIUrl":"10.1007/s13337-026-00972-y","url":null,"abstract":"<p><p>Tick-borne diseases caused by the Bhanja virus (BHAV) have recently emerged as a significant threat to both human and livestock health. Currently, there are no approved antiviral agents available to control BHAV infection, highlighting the urgent need to identify potential therapeutic targets and effective drugs. Since nucleoprotein is a key structural and functional component essential for the replication and assembly of RNA viruses, we hypothesized that inhibition of the BHAV nucleoprotein could suppress viral growth and replication. In this study, we employed a structure-based drug repurposing approach to identify existing antiviral compounds capable of targeting the BHAV nucleoprotein. The three-dimensional structure of the BHAV nucleoprotein was modeled and subjected to molecular docking with 50 known antiviral drugs. Among them, saquinavir demonstrated the highest binding affinity and most favorable interaction profile. To further evaluate the thermodynamic stability of the nucleoprotein-saquinavir complex, molecular dynamics (MD) simulations were performed for 150 ns in triplicate. The simulation analyses confirmed the structural stability and sustained interaction of saquinavir with the BHAV nucleoprotein over time. Overall, our findings suggest that saquinavir may serve as a promising repurposed therapeutic candidate for the inhibition of BHAV replication, offering a potential strategy for the control of tick-borne viral diseases.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"281-295"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FmdNspPred: A computational model for prediction of foot-and-mouth disease virus exposure of the susceptible animals using 2B NSP-ELISA data. FmdNspPred:利用2B NSP-ELISA数据预测易感动物口蹄疫病毒暴露的计算模型。
IF 1.3
VirusDisease Pub Date : 2026-09-01 Epub Date: 2026-06-23 DOI: 10.1007/s13337-026-00970-0
Samarendra Das, Bighneswar Barik, Jitendra Kumar Biswal, Rajeev Ranjan, Jajati Keshari Mohapatra, Rabindra Prasad Singh
{"title":"<i>FmdNspPred</i>: A computational model for prediction of foot-and-mouth disease virus exposure of the susceptible animals using 2B NSP-ELISA data.","authors":"Samarendra Das, Bighneswar Barik, Jitendra Kumar Biswal, Rajeev Ranjan, Jajati Keshari Mohapatra, Rabindra Prasad Singh","doi":"10.1007/s13337-026-00970-0","DOIUrl":"10.1007/s13337-026-00970-0","url":null,"abstract":"<p><p>Foot-and-mouth disease (FMD) is a serious transboundary infectious disease that affects all cloven-hoofed animals of economic importance. Non-structural protein (NSP)-ELISA diagnostic assays are extensively used to detect FMD virus exposure in susceptible animals. The available NSP assays require different cutoffs for their implementation, and these cutoffs are determined through empirical and statistical (bootstrap and OptimalCutpoints) approaches. Further, the slightest changes in the cutoffs significantly affect the performance of these assays. Therefore, this study presents a cutoff independent machine learning-based computational model, <i>FmdNspPred</i>, for the prediction of FMD virus exposure of the susceptible animals. Here, logistic regression models were trained on absorbance data of 2B NSP-ELISA from the bovine serum samples (<i>n</i> = 1355) collected from various locations in India. The repeated 5-fold cross-validation accuracy and sensitivity of the <i>FmdNspPred</i> model were found to be highest (96%±0.005, 98%) compared to the empirical (92%±0.01, 90%), bootstrap (94%±0.004, 94%), and OptimalCutpoints (94%±0.009, 94%) approaches on test data. On independent bovine serum samples (<i>n =</i> 151), the <i>FmdNspPred</i> model provided the highest accuracy, F1-score, and MCC (86%, 0.92, and 0.53) compared to the empirical (74%, 0.83, 0.44), bootstrap (76%, 0.84, 0.45), and OptimalCutpoints (82%, 0.89, 0.51) approaches. In addition, areas under the receiver operating characteristic and precision recall curves for the <i>FmdNspPred</i> <b>(92%</b>, <b>82%)</b> were computed higher than those of the existing approach <b>(85%</b>, <b>63%).</b> Next, the <i>FmdNspPred</i> was used to predict the FMD-exposure status of fresh unknown bovine serum samples (<i>n</i> = 25). The results suggested that 19 and 6 samples were predicted to be positive and negative for FMD virus exposure, respectively. For the users, the <i>FmdNspPred</i> model is implemented in a publicly accessible R software package (https://github.com/ICARNIFMD/FmdNspPred). The source R-code is also provided for large-scale and offline predictions (https://github.com/ICARNIFMD/FmdNspPred/tree/master/R). The proposed <i>FmdNspPred</i> model is cutoff independent and expresses virus exposure in terms of probabilistic values, which is easy for epidemiological interpretations.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13337-026-00970-0.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"37 3","pages":"357-371"},"PeriodicalIF":1.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书